Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,408 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
High diagnostic accuracy of quantitative SARS-CoV-2 spike-binding-IgG assay and correlation with in vitro viral neutralizing activity.
Iwamoto N, Takamatsu Y, Asai Y, Tsuchiya K, Matsuda K, Oshiro Y, Inamura N, Terada M, Nemoto T, Kimura M, Saito S, Morioka S, Kenji M, Mitsuya H, Ohmagari N. Iwamoto N, et al. Among authors: terada m. Heliyon. 2024 Jan 13;10(2):e24513. doi: 10.1016/j.heliyon.2024.e24513. eCollection 2024 Jan 30. Heliyon. 2024. PMID: 38304834 Free PMC article.
Factors associated with anti-SARS-CoV-2 IgG antibody production in patients convalescing from COVID-19.
Kutsuna S, Asai Y, Matsunaga A, Kinoshita N, Terada M, Miyazato Y, Nakamoto T, Suzuki T, Saito S, Endo M, Kanda K, Kenji M, Takasaki J, Hojo M, Ishizaka Y, Ohmagari N. Kutsuna S, et al. Among authors: terada m. J Infect Chemother. 2021 Jun;27(6):808-813. doi: 10.1016/j.jiac.2021.01.006. Epub 2021 Jan 18. J Infect Chemother. 2021. PMID: 33531292 Free PMC article.
SARS-CoV-2-neutralizing humoral IgA response occurs earlier but modest and diminishes faster compared to IgG response.
Takamatsu Y, Omata K, Shimizu Y, Kinoshita-Iwamoto N, Terada M, Suzuki T, Morioka S, Uemura Y, Ohmagari N, Maeda K, Mitsuya H. Takamatsu Y, et al. Among authors: terada m. bioRxiv [Preprint]. 2022 Jun 9:2022.06.09.495422. doi: 10.1101/2022.06.09.495422. bioRxiv. 2022. Update in: Microbiol Spectr. 2022 Dec 21;10(6):e0271622. doi: 10.1128/spectrum.02716-22. PMID: 35702154 Free PMC article. Updated. Preprint.
Trends of participants in convalescent plasma donation for COVID-19 in Japan as the pandemic evolved.
Suzuki T, Asai Y, Takahashi K, Sanada M, Shimanishi Y, Terada M, Sato L, Inada M, Yamada G, Akiyama Y, Oshiro Y, Shiratori K, Togano T, Takamatsu Y, Kenji M, Matsunaga A, Ishizaka Y, Nomoto H, Iwamoto N, Saito S, Kutsuna S, Morioka S, Ohmagari N. Suzuki T, et al. Among authors: terada m. Heliyon. 2023 Sep 29;9(10):e20568. doi: 10.1016/j.heliyon.2023.e20568. eCollection 2023 Oct. Heliyon. 2023. PMID: 37842585 Free PMC article.
Asymptomatic COVID-19 re-infection in a Japanese male by elevated half-maximal inhibitory concentration (IC50) of neutralizing antibodies.
Inada M, Ishikane M, Terada M, Matsunaga A, Maeda K, Tsuchiya K, Miura K, Sairenji Y, Kinoshita N, Ujiie M, Kutsuna S, Ishizaka Y, Mitsuya H, Ohmagari N. Inada M, et al. Among authors: terada m. J Infect Chemother. 2021 Jul;27(7):1063-1067. doi: 10.1016/j.jiac.2021.04.017. Epub 2021 Apr 24. J Infect Chemother. 2021. PMID: 33962861 Free PMC article.
Factors associated with high antibody titer following coronavirus disease among 581 convalescent plasma donors: A single-center cross-sectional study in Japan.
Suzuki T, Asai Y, Ide S, Fukuda S, Tanaka A, Shimanishi Y, Takahashi K, Terada M, Sato L, Sato M, Inada M, Yamada G, Miyazato Y, Akiyama Y, Nomoto H, Nakamoto T, Nakamura K, Togano T, Morioka S, Kinoshita-Iwamoto N, Saito S, Kutsuna S, Ohmagari N. Suzuki T, et al. Among authors: terada m. J Infect Chemother. 2022 Feb;28(2):206-210. doi: 10.1016/j.jiac.2021.10.012. Epub 2021 Oct 20. J Infect Chemother. 2022. PMID: 34756573 Free PMC article.
1,408 results